Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NY:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Press releases about
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Seven Summits Research Releases Alerts on GE, EMC, SGP, CNQ, and COH
February 10, 2009
from
PR Newswire
Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer’s Disease
February 09, 2009
from
Business Wire News Releases
BridgewaterEquity.com Free Fundamental Sector & Market Research on KG, BCR, SGP and POM
February 04, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Bridgewater Equity (BWE).
Read More
from
Marketwired News Releases
XplosiveStocks.com: DHI, PFE, DOW, S, M, SGP Hot Stock Alerts!
February 03, 2009
from
PR Newswire
Schering-Plough Reports Financial Results for 2008 Fourth Quarter, Full Year
February 03, 2009
from
PR Newswire
Brooke Shields and the Makers of COPPERTONE(R) Join Together to Launch COPPERTONE(R) NutraShield(TM) - New Sunscreen Contains Antioxidants That Promote Natural Skin Repair
January 27, 2009
from
PR Newswire
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
January 27, 2009
from
PR Newswire
Schering-Plough Selects Benefit Advocates for Health Advocacy
January 15, 2009
from
PR Newswire
New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available
January 14, 2009
from
PR Newswire
U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
January 14, 2009
from
PR Newswire
BenchmarkJournal.com (Complimentary) Analyst Review for RPM, SNH, SGP and MTW
January 09, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal.
Read More
from
Marketwired News Releases
Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
January 09, 2009
from
PR Newswire
Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings
January 06, 2009
from
PR Newswire
Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
December 31, 2008
from
PR Newswire
Schering-Plough Provides Update on Dividend Payment Date for Mandatory Convertible Preferred Stock
December 19, 2008
from
PR Newswire
Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
December 12, 2008
from
PR Newswire
Standard & Poor's Announces Changes to U.S. Indices
December 11, 2008
from
PR Newswire
Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
December 10, 2008
from
PR Newswire
BridgewaterEquity.com Free Fundamental Sector & Market Research on COP, BSX, SGP and XTO
December 08, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Bridgewater Equity (BWE).
Read More
from
Marketwired News Releases
CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
December 08, 2008
from
PR Newswire
Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
November 24, 2008
from
PR Newswire
Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
November 24, 2008
from
PR Newswire
Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease
November 24, 2008
from
PR Newswire
Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
November 24, 2008
from
PR Newswire
Redpoint Bio Signs Pharmaceutical Research Agreement with Schering Corporation
November 13, 2008
Redpoint Bio and the Schering-Plough Research Institute division of Schering Corporation to Collaborate on Taste Science Research for Pharmaceuticals
Read More
from
Business Wire News Releases
Seven Summits Research Releases Alerts on RIMM, JPM, SGP, BG, and MR
November 11, 2008
from
PR Newswire
Schering-Plough to Webcast R&D Update Meeting
November 07, 2008
from
PR Newswire
Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients
November 01, 2008
from
PR Newswire
Schering-Plough to Appeal Jury Decision in Missouri Reimbursement Case
October 30, 2008
from
PR Newswire
Sugammadex Study First to Show Rapid Reversal of Profound Rocuronium-Induced Muscle Relaxation is Possible
October 28, 2008
from
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here